1 Mavrokokki A, "The nature and frequency of bisphosphonates-associated osteonecrosis of the jaws in Australia" 65 : 415-423, 2007
2 "Task force on bisphosphonate-related osteonecrosis of the jaws: American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaw-2009 Update. Approved by the Board of Truste"
3 Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic" 61 : 1115-1118, 2003
4 Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases" 62 : 527-534, 2004
5 Silverman SL, "Osteonecrosis of the jaw and the role of bisphosphonate: a critical review" 122 : S33-S45, 2009
6 Watts NB, "Osteonecrosis of the jaw" 101 : 160-165, 2008
7 Woo SB, "Narrative review: bisphosphonates and osteonecrosis of the jaws" 144 : 753-761, 2006
8 Black DM, "HORIZON Pivotal Fracture Trial: Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis" 356 : 1809-1822, 2007
9 Cartsos VM, "Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people" 139 : 23-30, 2008
10 Khosla S, "American Society for Bone and Mineral Research: Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research" 22 : 1479-1491, 2007